Clifutinib not checked

Sunshine Lake Pharma Co., Ltd. · HEC73543

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
6 in total
Targets
 

What this is

How it works
Blocks a kinase, an enzyme that passes "grow" or "activate" signals inside cells. Most are cancer drugs.-tinib: tyrosine kinase inhibitors WHO name stem
How it’s given
“The queue 1 is divided into Induction therapy and Consolidation therapy and Maintenance treatment The queue 2 will receive oral Clifutinib Besylate once daily until disease progression or unacceptable toxicity occurs”In the company’s words, NCT05133882 on ClinicalTrials.gov
Tested for
Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult
Main trialPhase 3
“A randomized,multicenter, open-label Phase III, clinical study is conducted to evaluate the clinical benefit Clifutinib in Chinese patients with relapsed/ refractory (R/R) FLT3-mutated AML as shown with overall survival compared to salvage chemotherapy, and also to investigate the efficacy of Clifutinib as assessed by CR/CRh rate in these subjects.”In the company’s words, NCT05586074 on ClinicalTrials.gov
Other names
HEC73543

Other drugs for Leukemia, Acute Myeloid (AML)

All 140 drugs for Leukemia, Acute Myeloid (AML)

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Nov 2027 HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
Phase 1/2Recruiting 31 Dec 2027 A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Phase 1Not yet recruiting 23 Apr 2027 A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Phase 1Completed 8 Dec 2022 Clifutinib Food Effect Study in Healthy Subjects
Phase 1Completed 21 Aug 2023 A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
Phase 1Completed 5 Nov 2025 Clinical Study on the Mass Balance of Clifutinib
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Clifutinib

Following is part of Solo: you see every change to Clifutinib the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in